{
  "question_id": "hpqqq24003",
  "category": "hp",
  "educational_objective": "Manage drug-induced liver injury.",
  "metadata": {
    "care_types": [],
    "patient_types": [],
    "high_value_care": false,
    "question_updated": "12/27/2025"
  },
  "question_text": "A 32-year-old man is evaluated for a 1-week history of jaundice and pruritus. He completed treatment for sinusitis with amoxicillin-clavulanate 1 month ago. His sinusitis symptoms resolved with therapy.On physical examination, vital signs are normal. Jaundice is noted. Excoriations are seen on the extremities. The abdominal examination is normal.Laboratory studies:INR1.0Albumin3.8 g/dL (38 g/L)Alkaline phosphatase580 U/LHAlanine aminotransferase42 U/LHAspartate aminotransferase38 U/LHBilirubin, total8.6 mg/dL (147 Âµmol/L)HResults of an abdominal ultrasound are normal, with no evidence of biliary dilation, gallstones, or hepatic parenchymal abnormalities.",
  "question_stem": "Which of the following is the most appropriate next step in management?",
  "options": [
    {
      "letter": "A",
      "text": "Endoscopic retrograde cholangiopancreatography",
      "peer_percentage": 0
    },
    {
      "letter": "B",
      "text": "Liver biopsy",
      "peer_percentage": 0
    },
    {
      "letter": "C",
      "text": "Prednisone administration",
      "peer_percentage": 0
    },
    {
      "letter": "D",
      "text": "Continued observation",
      "peer_percentage": 0
    }
  ],
  "user_performance": {
    "user_answer": null,
    "correct_answer": "D",
    "result": null,
    "time_taken": null
  },
  "critique": "Continued observation (Option D) is the most appropriate next step in management of this patient, whose liver injury was most likely caused by amoxicillin-clavulanate. Drug-induced liver injury (DILI) is a rare adverse reaction to medication that can result in jaundice, liver failure, and, potentially, death. DILI can be induced by prescription, over-the-counter, and herbal/complementary and alternative medications as well as by nutritional supplements. Acetaminophen, antibiotics (particularly amoxicillin-clavulanate), and antiseizure drugs (phenytoin and valproate) are most commonly associated with DILI. Patients suspected of having DILI should be asked about exposure to medications and supplements in the past 6 months. The diagnosis of DILI is usually based on the following: exposure to a likely offending agent, elevated liver test results, exclusion of other causes of liver injury, and improvement or resolution of liver injury after drug discontinuation. The pattern of liver test abnormalities and histologic injury varies widely. Injury may be predominantly hepatocellular (e.g., acetaminophen), cholestatic (e.g., amoxicillin-clavulanate), or mixed (e.g., phenytoin). Because this patient completed the course of amoxicillin-clavulanate, no management beyond observation is needed. In most cases, resolution occurs after drug discontinuation. However, jaundice that occurs with cholestatic drug reactions can take months to resolve and may even progress to the need for liver transplantation.Endoscopic retrograde cholangiopancreatography (ERCP) (Option A) is used to treat biliary obstruction. In this patient, an ultrasound has confirmed the absence of biliary dilation; therefore, ERCP would not be beneficial.A liver biopsy (Option B) is rarely necessary in patients with DILI but is helpful in cases of uncertainty or suspected drug-induced autoimmune hepatitis. Zone 3 necrosis and eosinophilia are classic histologic findings in DILI, but other findings may include hepatitis, cholestasis, steatosis, or granulomas. This patient has a classic presentation and a cholestatic biochemical profile consistent with DILI associated with amoxicillin-clavulanate, making autoimmune hepatitis unlikely.No specific treatment is available for idiosyncratic DILI. The administration of glucocorticoids, such as prednisone (Option C), is not indicated unless a drug hypersensitivity reaction (drug reaction with eosinophilia and systemic symptoms [drug-induced hypersensitivity syndrome]) is suspected. The absence of a rash, fever, facial swelling, lymphadenopathy, and substantially elevated aminotransferase levels make a hypersensitivity reaction unlikely and prednisone unnecessary in this patient.",
  "critique_links": [],
  "key_points": [
    "Management of drug-induced liver injury requires identifying and discontinuing the offending drug; resolution of liver injury supports the diagnosis."
  ],
  "references": "Chalasani NP, Maddur H, Russo MW, et al; Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116:878-898. PMID: 33929376 doi:10.14309/ajg.0000000000001259",
  "related_content": {
    "syllabus": [
      "hpsec24006"
    ],
    "learning_plan_topic": ""
  },
  "media": {
    "tables": [
      "tables/inline_table_1.html"
    ],
    "images": [],
    "svgs": [],
    "videos": []
  },
  "media_metadata": {
    "figures": [],
    "tables": [
      {
        "table_id": "inline_table_1",
        "file": "tables/inline_table_1.html",
        "title": "Laboratory studies:",
        "short_title": null,
        "footnotes": [],
        "headers": []
      }
    ],
    "videos": [],
    "svgs": []
  },
  "extracted_at": "2025-12-27T00:29:28.717050-06:00"
}